Cite
Baseline nail disease in patients with moderate to severe psoriasis and response to treatment with infliximab during 1 year.
MLA
Rich, Phoebe, et al. “Baseline Nail Disease in Patients with Moderate to Severe Psoriasis and Response to Treatment with Infliximab during 1 Year.” Journal of the American Academy of Dermatology, vol. 58, no. 2, Feb. 2008, pp. 224–31. EBSCOhost, https://doi.org/10.1016/j.jaad.2007.07.042.
APA
Rich, P., Griffiths, C. E. M., Reich, K., Nestle, F. O., Scher, R. K., Li, S., Xu, S., Hsu, M.-C., & Guzzo, C. (2008). Baseline nail disease in patients with moderate to severe psoriasis and response to treatment with infliximab during 1 year. Journal of the American Academy of Dermatology, 58(2), 224–231. https://doi.org/10.1016/j.jaad.2007.07.042
Chicago
Rich, Phoebe, Christopher E M Griffiths, Kristian Reich, Frank O Nestle, Richard K Scher, Shu Li, Stephen Xu, Ming-Chun Hsu, and Cynthia Guzzo. 2008. “Baseline Nail Disease in Patients with Moderate to Severe Psoriasis and Response to Treatment with Infliximab during 1 Year.” Journal of the American Academy of Dermatology 58 (2): 224–31. doi:10.1016/j.jaad.2007.07.042.